Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72016-09-0994OAAI
EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)JOURNAL OF HEPATOLOGYIF332014-04-010PREAI
RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSISJOURNAL OF HEPATOLOGYIF332013-04-012OAAI
Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122011-03-01159OA
ONCE DAILY ALISPORIVIR (DEB025) PLUS PEGIFNALFA2A/RIBAVIRIN RESULTS IN SUPERIOR SUSTAINED VIROLOGIC RESPONSE (SVR24) IN CHRONIC HEPATITIS C GENOTYPE 1 TREATMENT NAIVE PATIENTSJOURNAL OF HEPATOLOGYIF332011-03-0129OAAI
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3GASTROENTEROLOGYIF25.12010-10-0169OA
EFFICACY OF STANDARD OF CARE THERAPY FOLLOWING EXPERIMENTAL DEBIO 025 TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS CJOURNAL OF HEPATOLOGYIF332010-04-012OAAI
The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C PatientsHEPATOLOGYIF15.82009-05-01213OAAI
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated interferon alpha-2a in treatment naive chronic HCV patientsJOURNAL OF HEPATOLOGYIF332008-01-0114PREAI
The phenotype of inflammatory infiltrate in acute (AVHC) and chronic (CVHC) type C hepatitis - A comparative analysisJOURNAL OF HEPATOLOGYIF332003-04-010PREAI
Histopathological and immunohistochemical features of acute type C hepatitisJOURNAL OF HEPATOLOGYIF332002-04-010PREAI
The significance of hepatic steatosis (HS) in chronic hepatitis B and CJOURNAL OF HEPATOLOGYIF332002-04-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向